Cross-talk between RORγt+ innate lymphoid cells and intestinal macrophages induces mucosal IL-22 production In Crohn's disease

Inflammatory Bowel Diseases

Volumn 20, Issue 8, 2014, Pages 1426-1434

  Mizuno, Shinta ^a   Mikami, Yohei ^a   Kamada, Nobuhiko ^b   Handa, Tango ^a   Hayashi, Atsushi ^a   Sato, Toshiro ^a   Matsuoka, Katsuyoshi ^a   Matano, Mami ^a   Ohta, Yuki ^c   Sugita, Akira ^d   Koganei, Kazutaka ^d   Sahara, Rikisaburo ^e   Takazoe, Masakazu ^e   Hisamatsu, Tadakazu ^a   Kanai, Takanori ^a  

^a KEIO UNIVERSITY   (Japan)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^c WASEDA UNIVERSITY   (Japan)

^d YOKOHAMA MUNICIPAL CITIZEN'S HOSPITAL   (Japan)

^e Social Health Insurance Medical Center   (Japan)

Author keywords

Crohn's disease; IL 22; Macrophages

Indexed keywords

CD14 ANTIGEN; CD45 ANTIGEN; CD56 ANTIGEN; CLAUDIN 1; INTERLEUKIN 22; INTERLEUKIN 23; INTERLEUKIN 7 RECEPTOR; PROTEIN; REG1 ALPHA; RETINOID RELATED ORPHAN RECEPTOR GAMMA; UNCLASSIFIED DRUG; INTERLEUKIN DERIVATIVE; INTERLEUKIN-22; MESSENGER RNA;

ARTICLE; CELL ACTIVATION; CELL CONTACT; CELL INTERACTION; CELL ISOLATION; CELL SUBPOPULATION; COCULTURE; CONTROLLED STUDY; CROHN DISEASE; CYTOKINE PRODUCTION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOPATHOGENESIS; IMMUNOREGULATION; INFLAMMATION; INNATE LYMPHOID CELL; INTESTINE EPITHELIUM; INTESTINE MUCOSA; LAMINA PROPRIA; LYMPHOID CELL; MACROPHAGE; MUCOSAL IMMUNITY; NEGATIVE FEEDBACK; PRIORITY JOURNAL; PROTEIN EXPRESSION; UPREGULATION; ANIMAL; CASE CONTROL STUDY; CELL CULTURE; COMPARATIVE STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; GENETICS; IMMUNOLOGY; INNATE IMMUNITY; LYMPHOCYTE; METABOLISM; MOUSE; PROGNOSIS; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

ANIMALS; BLOTTING, WESTERN; CASE-CONTROL STUDIES; CELLS, CULTURED; CROHN DISEASE; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; HUMANS; IMMUNITY, INNATE; INFLAMMATION; INTERLEUKIN-23; INTERLEUKINS; INTESTINAL MUCOSA; LYMPHOCYTES; MACROPHAGES; MICE; NUCLEAR RECEPTOR SUBFAMILY 1, GROUP F, MEMBER 3; PROGNOSIS; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 84905439631     PISSN: 10780998     EISSN: 15364844     Source Type: Journal    
DOI: 10.1097/MIB.0000000000000105     Document Type: Article

References (33)

1. Podolsky DK. Inflammatory bowel disease (1). N Engl J Med. 1991;325:928-937.
2. Mjosberg JM, Trifari S, Crellin NK, et al. Human IL-25- and IL-33-responsive type 2 innate lymphoid cells are defined by expression of CRTH2 and CD161. Nat Immunol. 2011;12:1055-1062.
3. Spits H, Artis D, Colonna M, et al. Innate lymphoid cells-a proposal for uniform nomenclature. Nat Rev Immunol. 2013;13:145-149.
4. Qiu J, Guo X, Chen ZM, et al. Group 3 innate lymphoid cells inhibit T-cell-mediated intestinal inflammation through aryl hydrocarbon receptor signaling and regulation of microflora. Immunity. 2013;39:386-399.
5. Zenewicz LA, Yancopoulos GD, Valenzuela DM, et al. Innate and adaptive interleukin-22 protects mice from inflammatory bowel disease. Immunity. 2008;29:947-957.
6. Takatori H, Kanno Y, Watford WT, et al. Lymphoid tissue inducer-like cells are an innate source of IL-17 and IL-22. J Exp Med. 2009;206:35-41.
7. Walker JA, Barlow JL, McKenzie AN. Innate lymphoid cells-how did we miss them? Nat Rev Immunol. 2013;13:75-87.
8. Fuchs A, Vermi W, Lee JS, et al. Intraepithelial type 1 innate lymphoid cells are a unique subset of IL-12- and IL-15-responsive IFN-gammaproducing cells. Immunity. 2013;38:769-781.
9. Geremia A, Arancibia-Carcamo CV, Fleming MP, et al. IL-23-responsive innate lymphoid cells are increased in inflammatory bowel disease. J Exp Med. 2011;208:1127-1133.
10. Crellin NK, Trifari S, Kaplan CD, et al. Regulation of cytokine secretion in human CD127 (+) LTi-like innate lymphoid cells by Toll-like receptor 2. Immunity. 2010;33:752-764.
11. Buonocore S, Ahern PP, Uhlig HH, et al. Innate lymphoid cells drive interleukin-23-dependent innate intestinal pathology. Nature. 2010;464:1371-1375.
12. Kamada N, Hisamatsu T, Okamoto S, et al. Unique CD14 intestinal macrophages contribute to the pathogenesis of Crohn disease via IL-23/IFN-gamma axis. J Clin Invest. 2008;118:2269-2280.
13. Ogino T, Nishimura J, Barman S, et al. Increased Th17-inducing activity of CD14+ CD163 low myeloid cells in intestinal lamina propria of patients with Crohn's disease. Gastroenterology. 2013;145:1380-1391.e1381.
14. Kanai T, Watanabe M, Okazawa A, et al. Macrophage-derived IL-18-mediated intestinal inflammation in the murine model of Crohn's disease. Gastroenterology. 2001;121:875-888.
15. Sujino T, Kanai T, Ono Y, et al. Regulatory T cells suppress development of colitis, blocking differentiation of T-helper 17 into alternative T-helper 1 cells. Gastroenterology. 2011;141:1014-1023.
16. Crellin NK, Trifari S, Kaplan CD, et al. Human NKp44+IL-22+ cells and LTi-like cells constitute a stable RORC+ lineage distinct from conventional natural killer cells. J Exp Med. 2010;207:281-290.
17. Bernink JH, Peters CP, Munneke M, et al. Human type 1 innate lymphoid cells accumulate in inflamed mucosal tissues. Nat Immunol. 2013;14:221-229.
18. Chinen H, Matsuoka K, Sato T, et al. Lamina propria c-kit+ immune precursors reside in human adult intestine and differentiate into natural killer cells. Gastroenterology. 2007;133:559-573.
19. Takayama T, Kamada N, Chinen H, et al. Imbalance of NKp44 (+) NKp46 (-) and NKp44 (-) NKp46 (+) natural killer cells in the intestinal mucosa of patients with Crohn's disease. Gastroenterology. 2010;139:882-892, 892.e881-e883.
20. Kamada N, Hisamatsu T, Honda H, et al. Human CD14+ macrophages in intestinal lamina propria exhibit potent antigen-presenting ability. J Immunol. 2009;183:1724-1731.
21. Zenewicz LA, Yin X, Wang G, et al. IL-22 deficiency alters colonic microbiota to be transmissible and colitogenic. J Immunol. 2013;190:5306-5312.
22. Wolk K, Kunz S, Witte E, et al. IL-22 increases the innate immunity of tissues. Immunity. 2004;21:241-254.
23. Pickert G, Neufert C, Leppkes M, et al. STAT3 links IL-22 signaling in intestinal epithelial cells to mucosal wound healing. J Exp Med. 2009;206:1465-1472.
24. Cella M, Fuchs A, Vermi W, et al. A human natural killer cell subset provides an innate source of IL-22 for mucosal immunity. Nature. 2009;457:722-725.
25. Sonnenberg GF, Monticelli LA, Elloso MM, et al. CD4 (+) lymphoid tissue-inducer cells promote innate immunity in the gut. Immunity. 2011;34:122-134.
26. Tomasello E, Yessaad N, Gregoire E, et al. Mapping of NKp46 (+) cells in healthy human lymphoid and non-lymphoid tissues. Front Immunol. 2012;3:344.
27. Dumoutier L, de Heusch M, Orabona C, et al. IL-22 is produced by gammaC-independent CD25+ CCR6+ innate murine spleen cells upon inflammatory stimuli and contributes to LPS-induced lethality. Eur J Immunol. 2011;41:1075-1085.
28. Mielke LA, Jones SA, Raverdeau M, et al. Retinoic acid expression associates with enhanced IL-22 production by gammadelta T cells and innate lymphoid cells and attenuation of intestinal inflammation. J Exp Med. 2013;210:1117-1124.
29. Vonarbourg C, Mortha A, Bui VL, et al. Regulated expression of nuclear receptor RORgammat confers distinct functional fates to NK cell receptor-expressing RORgammat (+) innate lymphocytes. Immunity. 2010;33:736-751.
30. Zheng Y, Valdez PA, Danilenko DM, et al. Interleukin-22 mediates early host defense against attaching and effacing bacterial pathogens. Nat Med. 2008;14:282-289.
31. Kimura K, Kanai T, Hayashi A, et al. Dysregulated balance of retinoidrelated orphan receptor gammat-dependent innate lymphoid cells is involved in the pathogenesis of chronic DSS-induced colitis. Biochem Biophys Res Commun. 2012;427:694-700.
32. Sato T, Vries RG, Snippert HJ, et al. Single Lgr5 stem cells build cryptvillus structures in vitro without a mesenchymal niche. Nature. 2009;459:262-265.
33. Sato T, Clevers H. Growing self-organizing mini-guts from a single intestinal stem cell: mechanism and applications. Science. 2013;340:1190-1194.